Research Library

As the world faces the latest wave of COVID-19, a vaccine produced by health fellow Peter Hotez and his colleague Maria Elena Bottazzi is ready to be deployed. Their CORBEVAX vaccine is inexpensive, effective, safe and easy to store and distribute, they write. Read their article in Scientific American: https://bit.ly/3n28isA

"The framework of science tikkun — repairing the world through science and global scientific cooperation — offers a path for countering a new rise in antiscience aggression," writes fellow Peter Hotez in The FASEB Journal. Find his perspective on how here.

A team of experts recommends community-based strategies for increasing vaccine acceptance in the USA as a means for controlling the COVID-19 pandemic.

"This is a moment to prioritise health over short-term political calculations," write fellow Peter Hotez, Rekha Lakshmanan
 and nine other experts in a Lancet commentary. Click here for their call for action against anti-vaccine rhetoric and COVID-19 misinformation, and five short-term recommendations.

Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.

Global deworming programs for children were once believed to improve a child’s chances for health, growth and success in school. New research that claims to debunk the merit of such programs has set off so-called “worm wars” between investigators. The authors aim to resolve the issue through an extended comparison of findings from key economics and epidemiological studies.

The authors discuss Pakistan’s challenges with neglected tropical diseases (NTDs) and their impact on poverty, child development and overall health in the country.